Clinical Trial Update: Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the safety and efficacy of MY008211A in patients with paroxysmal nocturnal hemoglobinuria (PNH) is listed as NOT_YET_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• MY008211A

Snippet

Sponsor: Wuhan Createrna Science and Technology Co., Ltd | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | Status: NOT_YET_RECRUITING